Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents

SARS-CoV-2 infections in children are generally asymptomatic or mild and rarely progress to severe disease and hospitalization. Why this is so remains unclear. Here we explore the potential for protection due to pre-existing cross-reactive seasonal coronavirus antibodies and compare the rate of anti...

書誌詳細
主要な著者:	Ratcliffe, H, Tiley, K, Longet, S, Tonry, C, Roarty, C, Watson, C, Amirthalingam, G, Vichos, I, Morey, E, Douglas, NL, Marinou, S, Plested, E, Aley, PK, Galiza, E, Faust, SN, Hughes, S, Murray, C, Roderick, MR, Shackley, F, Oddie, S, Lee, TWR, Turner, DPJ, Raman, M, Owens, S, Turner, PJ, Cockerill, H, Lopez Bernal, J, Ijaz, S, Poh, J, Shute, J, Linley, E, Borrow, R, Hoschler, K, Brown, KE, Carroll, MW, Klenerman, P, Dunachie, SJ, Ramsay, M, Voysey, M, Waterfield, T, Snape, MD
フォーマット:	Journal article
言語:	English
出版事項:	Elsevier 2023

類似資料

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
著者:: Helen Ratcliffe, 等
出版事項: (2023-12-01)

Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021
著者:: Ratcliffe, H, 等
出版事項: (2022)

The Role of Intestinal Epithelial Permeability in Multisystem Inflammatory Syndrome in Children: A Case–Control Study
著者:: Cathal Roarty, 等
出版事項: (2024-08-01)

PANDEMIC HUMAN CORONAVIRUS – CHARACTERIZATION AND COMPARISON OF SELECTED PROPERTIES OF HCOV-SARS AND HCOV-MERS
著者:: Katarzyna W. Pancer
出版事項: (2018-06-01)

Development of Primer Panels for Whole-Genome Amplification and Sequencing of Human Seasonal Coronaviruses: hCoV-OC43, hCoV-HKU1, hCoV-229E, and hCoV-NL63
著者:: Tamila Musaeva, 等
出版事項: (2024-12-01)

Seasonality and immunity to laboratory-confirmed seasonal coronaviruses (HCoV-NL63, HCoV-OC43, and HCoV-229E): results from the Flu Watch cohort study [version 2; peer review: 2 approved]
著者:: Robert W. Aldridge, 等
出版事項: (2020-12-01)

Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43
著者:: Virginia Fuochi, 等
出版事項: (2023-03-01)

Human Coronaviruses HCoV-NL63 and HCoV-HKU1 in Hospitalized Children with Acute Respiratory Infections in Beijing, China
著者:: Li-Jin Cui, 等
出版事項: (2011-01-01)

Seroconversion to HCoV-NL63 in Rhesus Macaques
著者:: Lia van der Hoek, 等
出版事項: (2009-10-01)

HCoV-NL63 and HCoV-HKU1 seroprevalence and its relationship with the clinical features of COVID-19 patients from Villavicencio, Colombia
著者:: Lida Carolina Lesmes-Rodríguez, 等
出版事項: (2024-08-01)

Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia
著者:: Sean A. Lynch, 等
出版事項: (2021-08-01)

The transcriptional and translational landscape of HCoV-OC43 infection.
著者:: Stefan Bresson, 等
出版事項: (2025-01-01)

Montelukast Inhibits HCoV-OC43 Infection as a Viral Inactivator
著者:: Yongkang Chen, 等
出版事項: (2022-04-01)

Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein
著者:: Jiangchao Xiang, 等
出版事項: (2022-11-01)

55: DEVELOPMENT OF A NOVEL IN-VITRO HCOV-OC43 SCREENING METHOD
著者:: S. Haynes, 等
出版事項: (2022-11-01)

The human coronavirus HCoV-229E S-protein structure and receptor binding
著者:: Zhijie Li, 等
出版事項: (2019-10-01)

Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)
著者:: Martin Dugas, 等
出版事項: (2021-04-01)

Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice
著者:: Alvaro A. Ordonez, 等
出版事項: (2022-03-01)

Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
著者:: Yongmei Feng, 等
出版事項: (2022-12-01)

Utilizing HCoV-OC43 to better understand the neurological impact of COVID-19
著者:: Catherine LaCourse
出版事項: (2024-12-01)

HCoV‐HKU1 and TMPRSS2 interaction: uncovering mechanisms of viral invasion
著者:: Zehan Pang, 等
出版事項: (2025-01-01)

Inhibition by components of Glycyrrhiza uralensis of 3CLpro and HCoV-OC43 proliferation
著者:: Jang Hoon Kim, 等
出版事項: (2023-12-01)

HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients
著者:: Sophie Steiner, 等
出版事項: (2020-12-01)

Co-circulation of Four Human Coronaviruses (HCoVs) in Queensland Children with Acute Respiratory Tract Illnesses in 2004
著者:: Theo P. Sloots, 等
出版事項: (2012-04-01)

Corrigendum: Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
著者:: Yongmei Feng, 等
出版事項: (2024-12-01)

Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China
著者:: Jing Yang, 等
出版事項: (2020-08-01)

Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry
著者:: Huan Sun, 等
出版事項: (2020-01-01)

Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro
著者:: Sébastien Pasquereau, 等
出版事項: (2021-02-01)

Disinfection Effect of High-pressure Carbon Dioxide on Human Coronavirus (hCoV-229E)
著者:: Peng NING, 等
出版事項: (2023-01-01)

A Mouse-Adapted Model of HCoV-OC43 and Its Usage to the Evaluation of Antiviral Drugs
著者:: Peifang Xie, 等
出版事項: (2022-05-01)

Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1
著者:: Nehemya Friedman, 等
出版事項: (2018-09-01)

IL6-mediated HCoV-host interactome regulatory network and GO/Pathway enrichment analysis.
著者:: Gianfranco Politano, 等
出版事項: (2020-09-01)

ESCRT Protein VPS4A Is Required for the Formation of Replication Centers and Replication of Human Coronavirus 229E (HCoV-229E)
著者:: Rinki Kumar, 等
出版事項: (2024-08-01)

Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection
著者:: Irene A. Abela, 等
出版事項: (2024-02-01)

Comparison of Selected Characteristics of SARS-CoV-2, SARS-CoV, and HCoV-NL63
著者:: Darina Bačenková, 等
出版事項: (2021-02-01)

Comparison of SARS-CoV-2- and HCoV-Specific T Cell Response Using IFN-γ ELISpot
著者:: Laura Thümmler, 等
出版事項: (2021-08-01)

Erythromycin Estolate Is a Potent Inhibitor Against HCoV-OC43 by Directly Inactivating the Virus Particle
著者:: Xiaohuan Wang, 等
出版事項: (2022-07-01)

Cryo-EM analysis of the HCoV-229E spike glycoprotein reveals dynamic prefusion conformational changes
著者:: Xiyong Song, 等
出版事項: (2021-01-01)

Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
著者:: Nehemya Friedman, 等
出版事項: (2021-01-01)

Nasopharyngeal carriage of pneumococcus in children in England up to 10 years after 13-valent pneumococcal conjugate vaccine introduction: persistence of serotypes 3 and 19A and emergence of 7C
著者:: Tiley, KS, 等
出版事項: (2022)